Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Galsky

Showing results (1-10 of 388) with videos related to

Pageof 39
Sort By:
The Oncologist|November 30, 2005
The role of taxanes in the management of bladder cancerMatthew D Galsky
The Lancet. Oncology|January 15, 2013
A prognostic model for metastatic renal-cell carcinomaMatthew D Galsky
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
New developments in urothelial cancerMatthew D Galsky
The Journal of Urology|August 21, 2012
Editorial commentMatthew D Galsky
Future Oncology (London, England)|August 23, 2014
Rethinking cancer clinical trials for the futureMatthew D Galsky
Nature Reviews. Urology|November 29, 2017
Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockadeMatthew D Galsky
Nature|July 18, 2018
Resistance to prostate-cancer treatment is driven by immune cellsMatthew D Galsky
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Bladder cancer: advances in treatment and researchMatthew D Galsky
The Lancet. Oncology|July 24, 2012
Antiangiogenic treatment in metastatic urothelial cancerMatthew D Galsky
Clinical Advances in Hematology & Oncology : H&O|July 8, 2014
New drugs and treatment strategies in prostate cancerMatthew D Galsky
Pageof 39

Showing results (1-10 of 388) with videos related to

Sort By:
Pageof 39
The Oncologist|November 30, 2005
The role of taxanes in the management of bladder cancerMatthew D Galsky
The Lancet. Oncology|January 15, 2013
A prognostic model for metastatic renal-cell carcinomaMatthew D Galsky
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
New developments in urothelial cancerMatthew D Galsky
The Journal of Urology|August 21, 2012
Editorial commentMatthew D Galsky
Future Oncology (London, England)|August 23, 2014
Rethinking cancer clinical trials for the futureMatthew D Galsky
Nature Reviews. Urology|November 29, 2017
Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockadeMatthew D Galsky
Nature|July 18, 2018
Resistance to prostate-cancer treatment is driven by immune cellsMatthew D Galsky
Clinical Advances in Hematology & Oncology : H&O|May 28, 2010
Bladder cancer: advances in treatment and researchMatthew D Galsky
The Lancet. Oncology|July 24, 2012
Antiangiogenic treatment in metastatic urothelial cancerMatthew D Galsky
Clinical Advances in Hematology & Oncology : H&O|July 8, 2014
New drugs and treatment strategies in prostate cancerMatthew D Galsky
Pageof 39